- Home
- JOB vs RLYB Comparison
JOB vs RLYB Comparison
Compare JOB & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JOB
- RLYB
- Stock Information
- Founded
- JOB 1893
- RLYB 2018
- Country
- JOB United States
- RLYB United States
- Employees
- JOB N/A
- RLYB N/A
- Industry
- JOB Diversified Commercial Services
- RLYB Biotechnology: Pharmaceutical Preparations
- Sector
- JOB Consumer Discretionary
- RLYB Health Care
- Exchange
- JOB Nasdaq
- RLYB Nasdaq
- Market Cap
- JOB 22.5M
- RLYB 24.1M
- IPO Year
- JOB N/A
- RLYB 2021
- Fundamental
- Price
- JOB $0.20
- RLYB $0.61
- Analyst Decision
- JOB
- RLYB Hold
- Analyst Count
- JOB 0
- RLYB 2
- Target Price
- JOB N/A
- RLYB N/A
- AVG Volume (30 Days)
- JOB 223.8K
- RLYB 264.8K
- Earning Date
- JOB 12-18-2025
- RLYB 11-07-2025
- Dividend Yield
- JOB N/A
- RLYB N/A
- EPS Growth
- JOB N/A
- RLYB N/A
- EPS
- JOB N/A
- RLYB N/A
- Revenue
- JOB $108,752,000.00
- RLYB $761,000.00
- Revenue This Year
- JOB $43.94
- RLYB N/A
- Revenue Next Year
- JOB N/A
- RLYB N/A
- P/E Ratio
- JOB N/A
- RLYB N/A
- Revenue Growth
- JOB N/A
- RLYB 154.51
- 52 Week Low
- JOB $0.17
- RLYB $0.22
- 52 Week High
- JOB $0.51
- RLYB $1.24
- Technical
- Relative Strength Index (RSI)
- JOB 45.34
- RLYB 62.14
- Support Level
- JOB $0.19
- RLYB $0.60
- Resistance Level
- JOB $0.21
- RLYB $0.68
- Average True Range (ATR)
- JOB 0.01
- RLYB 0.04
- MACD
- JOB -0.00
- RLYB 0.01
- Stochastic Oscillator
- JOB 53.82
- RLYB 69.74
About JOB GEE Group Inc.
GEE Group Inc is a provider of specialized staffing solutions across the United States. The company's operating segment includes Industrial Staffing Services and Professional Staffing Services. It generates maximum revenue from the Professional Staffing Services segment. The company provides the following services, direct hire placement services, temporary professional services staffing in the fields of information technology, accounting, finance and office, engineering, and medical, and temporary light industrial staffing.
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.